1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017


DelveInsight’s Report, “Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chemotherapy Induced Nausea and Vomiting Report is to understand the market and pipeline status of the drugs around the Chemotherapy Induced Nausea and Vomiting to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Chemotherapy Induced Nausea and Vomiting. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 48-72 Hours to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:
- A snapshot of the global Market and Phase III therapeutics scenario for Chemotherapy Induced Nausea and Vomiting.
- A review of the marketed products under prescription for Chemotherapy Induced Nausea and Vomiting, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Chemotherapy Induced Nausea and Vomiting with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Chemotherapy Induced Nausea and Vomiting drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Chemotherapy Induced Nausea and Vomiting drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Chemotherapy Induced Nausea and Vomiting drugs.
- Coverage of Chemotherapy Induced Nausea and Vomiting Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure to 2018.

Reasons to buy:
- Evaluate the marketing status and exclusivity details of Chemotherapy Induced Nausea and Vomiting key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Chemotherapy Induced Nausea and Vomiting.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Chemotherapy Induced Nausea and Vomiting.
- API intelligence over marketed drugs forChemotherapy Induced Nausea and Vomitingand gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III Pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Chemotherapy Induced Nausea and Vomiting.
- Uncovering opportunities in the rapidly growing US market.

Table Of Contents

Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
Illustrative
1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Chemotherapy Induced Nausea and Vomiting
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Chemotherapy Induced Nausea and Vomiting
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Chemotherapy Induced Nausea and Vomiting
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer


List of Tables

- Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, Marketed Drugs by Application Type, 2017
- Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017
- Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, (Year), 2017
- Chemotherapy Induced Nausea and Vomiting Marketed Drugs, API Manufacturers by US DMF Status, 2017
- Chemotherapy Induced Nausea and Vomiting Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Chemotherapy Induced Nausea and Vomiting Drugs, API Manufacturers, Europe by Country, 2017
- Chemotherapy Induced Nausea and Vomiting Drugs, API Manufacturers, India by State, 2017
- Chemotherapy Induced Nausea and Vomiting Drugs, API Manufacturers, China by Province, 2017
- Chemotherapy Induced Nausea and Vomiting Drugs, API Manufacturers by Geography 2017
- Chemotherapy Induced Nausea and Vomiting Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Chemotherapy Induced Nausea and Vomiting Therapeutic Market, Global Sales-2018 (in million USD)
- API Manufacturers for Drug, 2017
- Phase III Drugs for Chemotherapy Induced Nausea and Vomiting, 2017
- Discontinued Drugs for Chemotherapy Induced Nausea and Vomiting, 2017


List of Figures

- Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017
- Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017
- Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, (Year), 2017
- Chemotherapy Induced Nausea and Vomiting Marketed Drugs, API Manufacturers by US DMF Status (%), 2017
- Chemotherapy Induced Nausea and Vomiting Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Chemotherapy Induced Nausea and Vomiting Drugs, API Manufacturers, Europe by Country, 2017
- Chemotherapy Induced Nausea and Vomiting Drugs, API Manufacturers, India by State, 2017
- Chemotherapy Induced Nausea and Vomiting Drugs, API Manufacturers, China by Province, 2017
- Chemotherapy Induced Nausea and Vomiting Drugs, API Manufacturers by Geography 2017
- Chemotherapy Induced Nausea and Vomiting Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Chemotherapy Induced Nausea and Vomiting Therapeutic Market, Global Sales 2018 (in million USD)
- Drug, Patent/Exclusivity Expiry (Year), 2017

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Erectile Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Erectile Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Erectile Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Female Sexual Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Female Sexual Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Female Sexual Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in the UK - Forecast

  • September 2016
    33 pages
  • Anti-Infective  

  • United Kingdom  

    World  

View report >

Global Anti-Infective Market - Forecast

  • May 2016
    84 pages
  • Anti-Infective  

    Infectious Dise...  

  • World  

    United States  

View report >

Global Anti-Infective Market - Forecast

  • May 2016
    84 pages
  • Anti-Infective  

    Infectious Dise...  

  • World  

    United States  

View report >

Insulin Market In The Us

10 months ago

Related Market Segments :

Cloud Computing
Chemotherapy

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.